drugset / Trial / NCT00217828

Effects of Citalopram on Hostility and CHD Risk

NCT00217828

RandomizedTreatment

Summary

To evaluate the therapeutic effects of the serotonergic agent, citalopram, on hostility and other behavioral risk factors, and biological markers of disease risk (serum lipids, insulin and glucose; autonomic balance and stress-related cardiovascular reactivity; platelet activation).

Timeline

Start
2002-03
Primary completion
2003-02
Completion
2003-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule

Indications